Knowing when to bring up this treatment option can help ensure it's discussed at the right time.
Typically, CAR T-cell therapy is considered in the following situations: if you have tried the standard therapy and it didn’t control the myeloma as expected, or if you have undergone multiple therapies and they have stopped working or had to be discontinued because of side effects.
Learn more about how doctors determine eligibility: CAR-T Criteria
